Pediatric Endocrinology Diabetes and Metabolism

The epidemic of childhood obesity and the COVID-19 pandemic: metabolic characteristics and effects of therapy

Kalina Fabin-Czepiel 1, 2
,
Agnieszka Zachorzuk 3
,
Karolina Pieczyńska-Chapuła 1, 2
,
Aleksandra Pyziak-Skupień 1
,
Paweł Matusik 4
,
Przemysława Jarosz-Chobot 1, 5
,
Grażyna Deja 1, 5

  1. Saint John Paul II Upper Silesian Child Health Centre, Public Clinical Hospital No. 6, Medical University of Silesia in Katowice, Poland

  2. Department of Pediatric Neurology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Poland

  3. Department of Pediatrics, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Zabrze, Poland

  4. Department of Pediatrics, Pediatric Obesity and Metabolic Bone Diseases, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Poland

  5. Department of Children, Diabetology and Lifestyle Medicine, Faculty of Medical Sciences,
    Medical University of Silesia in Katowice, Poland

Endocrinol Diabetes Metab 2026; 32 (2):

DOI: https://doi.org/10.5114/pedm.2026.161141
Data publikacji online: 2026/06/05
Article file
0415_The epidemic of childhood.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. World Obesity Federation. World obesity atlas 2023. London: World Obesity Federation; 2023.
  2. OECD. WHO health at a glance: Asia/Pacific 2020: measuring progress towards universal health coverage. Paris: OECD Publishing; 2020.
  3. Gao L, Peng W, Xue H, et al. Spatial–temporal trends in global childhood overweight and obesity from 1975 to 2030: a weight mean center and projection analysis of 191 countries. Glob Health 2023; 19: 53. doi: 10.1186/s12992-023-00954-5.
  4. Global Obesity Observatory. Country profile: Poland. Available at: https://data.worldobesity.org/country/poland-173/ (accessed 19 Nov 2024).
  5. Majcher A, Czerwonogrodzka-Senczyna A, Kądziela K, et al. Development of obesity from childhood to adolescents. Pediatr Endocrinol Diabetes Metab 2021; 27: 70–75. doi: 10.5114/pedm.2021.105297.
  6. Śliwowska JH, Wójcik M, El Ghoch M, Delvecchio M. Metabolic consequences in children and adolescents with obesity: latest insights. Front Endocrinol (Lausanne) 2023; 14: 1223129. doi: 10.3389/fendo.2023.1223129.
  7. Kozioł-Kozakowska A, Januś D, Stępniewska A, et al. Beyond the metabolic syndrome: non-obvious complications of obesity in children. Children (Basel) 2023; 10: 1905. doi: 10.3390/children10121905.
  8. Wrzosek M, Wiśniewska K, Sawicka A, et al. Early onset of obesity and adult onset of obesity as factors affecting patient characteristics prior to bariatric surgery. Obes Surg 2018; 28: 3902–3909. doi: 10.1007/s11695-018-3381-y.
  9. Fabin-Czepiel K, Pieczyńska-Chapuła K, Deja G. “The obesity pandemic” in the COVID-19 pandemic – new treatment for an old problem. Pediatr Endocrinol Diabetes Metab 2023; 29: 104–111. doi: 10.5114/pedm.2023.129342.
  10. Moore JB. COVID-19, childhood obesity, and NAFLD: colliding pandemics. Lancet Gastroenterol Hepatol 2022; 7: 499–501. doi: 10.1016/S2468-1253(22)00100-5.
  11. Anderson LN, Yoshida-Montezuma Y, Dewart N, et al. Obesity and weight change during the COVID-19 pandemic in children and adults: a systematic review and meta-analysis. Obes Rev 2023; 24: e13550. doi: 10.1111/obr.13550.
  12. Runacres A, Mackintosh KA, Knight RL, et al. Impact of the COVID-19 pandemic on sedentary time and behaviour in children and adults: a systematic review and meta-analysis. Int J Environ Res Public Health 2021; 18: 11286. doi: 10.3390/ijerph182111286.
  13. Zachurzok A, Wójcik M, Gawlik A, et al. An attempt to assess the impact of pandemic restrictions on the lifestyle, diet, and body mass index of children with endocrine diseases – preliminary results. Nutrients 2022; 14: 156. doi: 10.3390/nu14010156.
  14. Jenssen BP, Kelly MK, Powell M, et al. COVID-19 and changes in child obesity. Pediatrics 2021; 147: e2021050123. doi: 10.1542/peds.2021-050123.
  15. Ab Khan M, Moverley Smith JE. “Covibesity,” a new pandemic. Obes Med 2020; 19: 100282. doi: 10.1016/j.obmed.2020.100282.
  16. Ahn MB, Kim SK, Kim SH, et al. Clinical significance of the fetuin-A-to-adiponectin ratio in obese children and adolescents with diabetes mellitus. Children (Basel) 2021; 8: 1155. doi: 10.3390/children8121155.
  17. Kącka A, Charemska A, Jarocka-Cyrta E, Głowińska-Olszewska B. Comparison of novel markers of metabolic complications and cardiovascular risk factors between obese non-diabetic and obese type 1 diabetic children and young adults. Front Endocrinol (Lausanne) 2022; 13: 1036109. doi: 10.3389/fendo.2022.1036109.
  18. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 2008; 93: 4479–4485. doi: 10.1210/jc.2008-1505.
  19. Gavril OI, Adam CA, Stamate TC, et al. Fetuin-A as a link between dyslipidemia and cardiovascular risk in type 2 diabetes: a metabolic insight for clinical practice. Biomedicines 2025; 13: 2098. doi: 10.3390/biomedicines13092098.
  20. Grajda A, Gurzkowska B, Wojtyło M, et al. Percentile charts for growth and nutritional status assessment in Polish children and adolescents from birth to 18 year of age. Stand Med Pediatr 2015; 12: 119–135.
  21. Centers for Disease Control and Prevention (CDC). Percentile data files with LMS values. Available at: http://www.cdc.gov/growthcharts/percentile_data_files.htm (accessed 23 Jun 2020).
  22. BCM. BMI z-score and percentile calculator. Available at: https://www.bcm.edu/bodycomp (accessed 19 Nov 2024).
  23. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25–29. doi: 10.1136/adc.73.1.25.
  24. Araszkiewicz A, Bandurska-Stankiewicz E, Borys S, et al. 2022 guidelines on the management of patients with diabetes: a position of Diabetes Poland. Curr Top Diabetes 2022; 2: 1–130.
  25. Kułaga Z, Grajda A, Gurzkowska B, et al. Centile charts for blood pressure assessment in children and adolescents aged 3–18 years. Stand Med Pediatr 2013; 1: 22–30.
  26. Kułaga Z, Litwin M, Grajda A, et al. Distribution of blood pressure in school-aged children and adolescents reference population. Stand Med Pediatr 2010; 7: 853–864.
  27. WHO. Physical activity. Available at: https://www.who.int/news-room/fact-sheets/detail/physical-activity (accessed 19 Nov 2024).
  28. Cunningham SA, Hardy ST, Jones R, et al. Changes in the incidence of childhood obesity. Pediatrics 2022; 150: e2021053708.
  29. Neville RD, Lakes KD, Hopkins WG, et al. Global changes in child and adolescent physical activity during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Pediatr 2022; 176: 886–894. doi: 10.1001/jamapediatrics.2022.2313.
  30. Miao X, Alidadipour A, Saed V, et al. Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation. Acta Diabetol. 2024; 61: 1339–1361. doi: 10.1007/s00592-024-02335-9.
  31. Pal D, Dasgupta S, Kundu R, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012; 18: 1279–1285. doi: 10.1038/nm.2851.
  32. Icer MA, Yıldıran H. Effects of nutritional status on serum fetuin-A level. Crit Rev Food Sci Nutr 2020; 60: 1938–1946. doi: 10.1080/10408398.2019.1631751.
  33. Şiraz ÜG, Doğan M, Hatipoğlu N, et al. Can fetuin-A be a marker for insulin resistance and poor glycemic control in children with type 1 diabetes mellitus? J Clin Res Pediatr Endocrinol 2017; 9: 293–299. doi: 10.4274/jcrpe.4532.
  34. Mazur A, Zachurzok A, Baran J, et al. Childhood obesity: position statement of Polish Society of Pediatrics, Polish Society for Pediatric Obesity, Polish Society of Pediatric Endocrinology and Diabetes, the College of Family Physicians in Poland and Polish Association for Study on Obesity. Nutrients 2022; 14: 3806. doi: 10.3390/nu14183806.
  35. Jung CH, Kim BY, Kim CH, et al. Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes. Diab Vasc Dis Res 2013; 10: 459–467. doi: 10.1177/1479164113490766.
SUBMIT YOUR PAPER
Share
without publication fees
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications